In my personal view 2026 will be a defining point for #AVCT and ultimately for long term cancer patients.
Thanks to all shareholders and stakeholders for their support.
On the train back to the West Country after the Avacta Science Day and a glorious number of pints.
Absolutely mind blowing what #AVCT $AVCT has already achieved. It has built a delivery platform for all anti-cancer warheads that could make the antibody-drug conjugate class, essentially obsolete, in a few short years - for pretty much 85-90% of all cancer cases worldwide.
The UK investment community appears to be maxed out in buying the stock. In reality, we need US and other international punters to set eyes on the stock for the first time and realise what an absolute diamond the pre|CISION platform is.
In the bull-case (which appears eminently achievable after today), that platform becomes the omnipresent delivery platform for all small molecule and biologics drugs treating solid tumours.
That’s almost 90% of the global oncology market. In 5 years, that’ll be >$500bn pa.
Wake up, ex-UK punters!
@Cumulus51896691@RAH00084 This is exactly what I’ve been feeling. A quiet internal thought to myself each and every day for the last 5 years. Each month I’ve faithfully added to my stack, some months I’ve had tremors of worry at 35p but I’ve kept adding and keeping the faith. Time to ring the bell 🔔
@55_retire Gotta start with a 5 minimum…. £50b will suffice - whole platform… revolutionise Cancer treatment… unlimited profits and cancer sufferers everywhere given hope without compromise!
@DrJN_SportsMed Wishing you a rapid and full recovery James. We’ve all seen patients like this and IT CAN turn around. Timescales maybe stretched but be patient, you will prevail 💪🏼⭐️